Natural Alternatives International Debuts TriBsyn™ at ESPEN Conference

Natural Alternatives International Unveils New Ingredient at ESPEN Conference

Natural Alternatives International, Inc. (NAI), a leading formulator, manufacturer, and marketer of nutritional supplements, has announced promising developments in its business strategy and product offerings. At the recent ESPEN conference in Milan, Italy, NAI introduced its innovative, patent-pending carnosine boosting ingredient, TriBsyn™. This groundbreaking product is the world’s first paresthesia-free beta-alanine, aimed at revolutionizing the medical foods industry.

NAI's leadership expressed optimism about the company's growth trajectory, highlighting a robust pipeline of new business opportunities that are expected to drive sales growth and restore profitability. "Our new business opportunity pipeline remains healthy, and we are optimistic these opportunities will generate positive sales growth and pave our pathway back to profitability," stated the company.

In conjunction with these developments, NAI has updated its investor presentation, which is now available on the investor relations page of their website. This presentation provides further insights into the company's strategic direction and financial performance.

Financial Performance Highlights

NAI's recent financial results indicate a challenging period, with net sales for the fiscal year ending June 30, 2024, reported at $113.8 million, down from $154 million the previous year. Despite a decrease in sales, the company remains focused on strategic initiatives to enhance profitability and market presence.

The company's comprehensive partnership approach continues to offer clients a wide range of services, including scientific research, clinical studies, proprietary ingredients, and international product registration assistance. These services are designed to support customer-specific nutritional product formulation and marketing efforts.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties. These statements reflect NAI's intentions, expectations, and beliefs concerning future events, including sales growth and economic conditions. Readers are cautioned that actual results may differ materially from those projected in the forward-looking statements.

For more detailed financial data and company information, please visit NAI's website. For investor inquiries, contact Michael Fortin, Chief Financial Officer, at 760-736-7700 or via email at investor@nai-online.com.